GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,339.00p
   
  • Change Today:
    -0.60p
  • 52 Week High: 1,742.20
  • 52 Week Low: 1,190.80
  • Currency: UK Pounds
  • Shares Issued: 5,031m
  • Volume: 910,013
  • Market Cap: 67,371m
  • RiskGrade: 129
  • Beta: 0.02

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 6.0% 5.9%
Div Cover 1.4 1.2
Op Mrgn 22.8% 21.9%
ROCE 66.0%  
Latest F'cast
P/E 11.6 13.7
PEG n/a n/a
Pr/Revenue 2.0 2.0
Pr/Book 3.2  
Latest F'cast
Revenue 1.0% -2.5%
PBT 12.0% 4.7%
EPS -6.5% -15.7%
DPS n/a -0.5%

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%
31-Dec-18 30,821.00 4,800.00 119.40p 12.5 1.8 +7% 80.00p 5.4%
31-Dec-19 33,754.00 6,221.00 123.90p 14.4 3.6 +4% 80.00p 4.5%
31-Dec-20 34,099.00 6,968.00 115.90p 11.6 n/a -6% 80.00p 6.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 33,263.50 7,293.85 97.73p 13.7 n/a -16% 79.56p 5.9%
31-Dec-22 35,024.07 8,037.79 108.96p 12.3 1.1 +12% 59.28p 4.4%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

Result of AGM 05-May-2021 18:23 RNS
Total Voting Rights 04-May-2021 16:29 RNS
Director/PDMR Shareholding 28-Apr-2021 17:33 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
28-Apr-21 Buy Urs Rohner 1,340.00p 629 8,428.60
28-Apr-21 Buy Judy Lewent 1,887.50p 688 12,986.00
28-Apr-21 Buy Jesse Goodman 1,353.79p 722 9,774.39

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,339.00p
Change Today -0.60p
% Change -0.04 %
52 Week High 1,742.20
52 Week Low 1,190.80
Volume 910,013
Shares Issued 5,031m
Market Cap 67,371m
Beta 0.02
RiskGrade 129

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.13% above the market average92.13% above the market average92.13% above the market average92.13% above the market average92.13% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
82.92% below the market average82.92% below the market average82.92% below the market average82.92% below the market average82.92% below the market average
75.44% below the sector average75.44% below the sector average75.44% below the sector average75.44% below the sector average75.44% below the sector average
Income
93.03% above the market average93.03% above the market average93.03% above the market average93.03% above the market average93.03% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
39.72% above the market average39.72% above the market average39.72% above the market average39.72% above the market average39.72% above the market average
57.89% below the sector average57.89% below the sector average57.89% below the sector average57.89% below the sector average57.89% below the sector average

What The Brokers Say

Strong Buy 9
Buy 1
Neutral 13
Sell 0
Strong Sell 3
Total 26
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q1 Q4
Ex-Div 20-May-21 18-Feb-21
Paid 08-Jul-21 08-Apr-21
Amount 19.00p 23.00p

Trades for 06-May-2021

Time Volume / Share Price
11:02 133 @ 1,339.00p
11:02 680 @ 1,339.00p
11:02 196 @ 1,339.00p
11:02 30 @ 1,339.00p
11:01 26 @ 1,339.00p

GlaxoSmithKline Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page